Article: 5 Minute Read

How We Standardized Deploying Vaccine Studies in Five Weeks

Medable launched its new vaccine offering, providing the industry with the speed, ease, and expertise needed to launch vaccine studies in as little as 5 weeks. 

Musaddiq Khan, VP of DCT Solutions, explains the cross collaborative effort taken to create this new offering, its benefits, and why hybrid/decentralized solutions are the perfect fit for vaccine trials. 

Download the full article here.

Musaddiq is a VP, DCT Solutions, Vaccines, Infectious Diseases & Respiratory at Medable.

Save the Date!
Download Now